Naomi Winick

22.1k total citations · 3 hit papers
238 papers, 9.6k citations indexed

About

Naomi Winick is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Naomi Winick has authored 238 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Public Health, Environmental and Occupational Health, 126 papers in Pediatrics, Perinatology and Child Health and 79 papers in Hematology. Recurrent topics in Naomi Winick's work include Acute Lymphoblastic Leukemia research (180 papers), Childhood Cancer Survivors' Quality of Life (120 papers) and Acute Myeloid Leukemia Research (45 papers). Naomi Winick is often cited by papers focused on Acute Lymphoblastic Leukemia research (180 papers), Childhood Cancer Survivors' Quality of Life (120 papers) and Acute Myeloid Leukemia Research (45 papers). Naomi Winick collaborates with scholars based in United States, Canada and Australia. Naomi Winick's co-authors include Meenakshi Devidas, Stephen P. Hunger, William L. Carroll, Bruce M. Camitta, Michael J. Borowitz, Elizabeth A. Raetz, Mignon L. Loh, Paul S. Gaynon, Andrew J. Carroll and Xiaomin Lu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Naomi Winick

232 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

2012 814 citations Stephen P. Hunger, Xiaomin Lu et al. Journal of Clinical Oncology profile →
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

2008 542 citations Michael J. Borowitz, Meenakshi Devidas et al. Blood profile →
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

2014 304 citations Kirk R. Schultz, Andrew J. Carroll et al. Leukemia profile →

Peers

Countries citing papers authored by Naomi Winick

Since Specialization

Citations

This map shows the geographic impact of Naomi Winick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Winick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Winick more than expected).

Fields of papers citing papers by Naomi Winick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Winick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Winick. The network helps show where Naomi Winick may publish in the future.

Co-authorship network of co-authors of Naomi Winick

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Winick. A scholar is included among the top collaborators of Naomi Winick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Winick. Naomi Winick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	An Integrated Method to Evaluate the Treatment Efficacy and Immunogenicity of B‐Cell Acute Lymphoblastic Leukemia Therapeutic Enzyme Formulations	Small Methods	Adam W. Woodward, Naomi Winick et al.	0
2	Higher Rates of Hypersensitivity Reactions to Calaspargase Compared With Pegaspargase: A Single Center Retrospective Review	Pediatric Blood & Cancer	Caroline Smith, Song Zhang et al.	0
3	Assessment of proxy‐reported responses as predictors of motor and sensory peripheral neuropathy in children with B‐lymphoblastic leukemia	Pediatric Blood & Cancer	Emily Hibbitts, Meenakshi Devidas et al.	2
4	Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia	JNCI Journal of the National Cancer Institute	John A. Kairalla, Emily Hibbitts et al.	12
5	Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children’s Oncology Group Study AALL0232	Leukemia	Michael J. Burke, Meenakshi Devidas et al.	12
6	Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331	Journal of Clinical Oncology	Leonard A. Mattano, Meenakshi Devidas et al.	22
7	Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group	Journal of Clinical Oncology	Sumit Gupta, Cindy Wang et al.	124
8	Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932	Blood	Anne Angiolillo, Reuven J. Schore et al.	4
9	Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL	Blood	Brent L. Wood, David Wu et al.	130
10	Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high‐risk stratum of patients with newly diagnosed high‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131	Cancer	Wanda L. Salzer, Michael J. Burke et al.	39
11	Longitudinal analysis of quality‐of‐life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial	Cancer	Daniel J. Zheng, Xiaomin Lu et al.	29
12	Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232	Journal of Clinical Oncology	Eric Larsen, Meenakshi Devidas et al.	231
13	Perceptions of the Pediatric Hospice Experience among English- and Spanish-Speaking Families	Journal of Palliative Medicine	Rachel Thienprayoon, Emily Marks et al.	47
14	Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331	Blood	Leonard A. Mattano, Meenakshi Devidas et al.	13
15	T-Lymphoblastic Leukemia (T-ALL) Shows Excellent Outcome, Lack of Significance of the Early Thymic Precursor (ETP) Immunophenotype, and Validation of the Prognostic Value of End-Induction Minimal Residual Disease (MRD) in Children’s Oncology Group (COG) Study AALL0434	Blood	Brent L. Wood, Stuart S. Winter et al.	97
16	Genome-wide study of methotrexate clearance replicates SLCO1B1	Blood	Laura B. Ramsey, John C. Panetta et al.	157
17	Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study	Journal of Clinical Oncology	Kirk R. Schultz, W. Paul Bowman et al.	436
18	Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies	Pharmacogenetics	Javier G. Blanco, Mathew J. Edick et al.	77
19	Evidence for Negative Feedback of Extracellular Methotrexate on Blasts of Acute Lymphoblastic Leukemia in Vitro	Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	Angela K. Smith, Richard H. Lark et al.	6
20	Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five-Day Course in Children with Refractory Solid Tumors	Journal of Pediatric Hematology/Oncology	David G. Tubergen, Clinton F. Stewart et al.	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact